Previous
Pause
Next
Skip to Navigation
↓
Congresses
Year
Year
Year
-Year
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Researcher
- Any -
cristinapozo
dgomez
usuario_prueba
Almeida e Silva, Filomena Augusta
Amorín , Ricardo
Angás Pajas, Jorge
Arenal , Raúl
Baptista , Pedro Miguel
Bernechea Navarro, María
Bover Arbós, Pere
Calvo Lacosta, Jorge Hugo
Carstensen , Hans-Heinrich
Castro Barrigón, Alberto
Cazcarro Castellano, Ignacio
Cobarrubias Baglietto, Sebastián Felipe
DeMiguel , Daniel
Espina Cadena, Laura
Fernandez Antoran, David
Ferrio Díaz, Juan Pedro
Gil Hernández, Vanesa
Gracia Lostao, Ana Isabel
Gurauskis , Jonas
Hernández Ainsa, Silvia
Hernández Latas, José Antonio
Hurtado Guerrero, Ramón
Jiménez Schuhmacher, Alberto
Juarez-Perez , Emilio J.
Köhler , Ralf
Martínez-Padilla , Jesús
Millán Gasca, Javier
Montiel , Manuel
Muñoz Soro, José Félix
Olmo , Jose
Ordovás Vidal, Laura
Philippidis , George
Ramón García, Santiago
Roque , Carla
Schoorlemmer , Jon
Sola , Daniel
Stavridis , Stelios
Sánchez Martínez, Diego
Velasco Lozano, Susana
Íñiguez Dieste, David
Title
Title
Year
Shortening Buruli Ulcer treatment: the BLMS4BU clinical trial
2022
Shortening Buruli ulcer treatment: the BLMs4BU clinical trial
2022
Shortening Buruli ulcer treatment: WHO recommended <i>vs.</i> a novel betalactam containing therapy - Phase II and Phase III studies in West Africa (the BLMs4BU clinical trial)
2022
Strategies to elucidate the mode of action of the avermectins against mycobacteria
2021
Study of in vitro and in vivo activity of a novel compound against Mycobacterium abscessus for the treatment of cystic fibrosis infections
2022
The D2AMR group: Discovery and development of Antimicrobials and Mechanisms of drug Resistance
2017
The veterinary anthelmintic selamectin inhibits the mycobacterial DprE1 enzyme
2022
Towards efficient in vitro screening tools to discover new clinical options in the treatment of non-tuberculous Mycobacteria
2019
Towards the elucidation of rifampicin/betalactam synergistic interactions against M. tuberculosis
2018
TOWARDS THE ELUCIDATION OF THE MODE OF ACTION OF A NEW CHEMICAL SERIES WITH ANTIMICROBIAL ACTIVITY
2019
Towards the elucidation of the rifampicin/beta-lactam synergy in mycobacteria
2019
Towards the elucidation of the rifampicin/beta-lactam synergy in mycobacteria
2019
Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening
2019
Pages
« primera
‹ anterior
1
2
3
4